Skip to main content
MedPathMedPath Home
Clinical Trials/EUCTR2007-002949-20-GB
EUCTR2007-002949-20-GB
Active, not recruiting
Phase 1

Randomised controlled trial comparing the effects of oxytocin 5 units IV bolus vs oxytocin 5 units IV infusion on cardiac output during caesarean section - Effect on cardiac output of oxytocin bolus vs. infusion

iverpool Women's NHS Foundation Trust0 sites32 target enrollmentFebruary 15, 2008
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
DrugsSyntocinon

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
iverpool Women's NHS Foundation Trust
Enrollment
32
Status
Active, not recruiting
Last Updated
6 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 15, 2008
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional clinical trial of medicinal product

Investigators

Sponsor
iverpool Women's NHS Foundation Trust

Eligibility Criteria

Inclusion Criteria

  • •All patients who are due to undergo elective caesarean section under spinal anaesthesia at more than 37 weeks gestation; ASA grade 1 or 2; age 18 or over.
  • •Are the trial subjects under 18? no
  • •Number of subjects for this age range:
  • •F.1\.2 Adults (18\-64 years) yes
  • •F.1\.2\.1 Number of subjects for this age range
  • •F.1\.3 Elderly (\>\=65 years) no
  • •F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • •Conversion to general anaesthetic; placenta praevia; diabetes mellitus; pregnancy induced hypertension; chronic hypertension; patients requiring peri\-operative therapeutic anti\-coagulant therapy; pre operative anaemia; liver disease; chronic renal failure; history of anaphylaxis to oxytocin.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Randomised controlled trial to compare the effects of granulocyte-colony stimulating factor (G-CSF) and autologous bone marrow progenitor cells infusion on quality of life and left ventricular function in patients with heart failure secondary to ischaemic heart disease
ISRCTN68837678Barts and the London NHS Trust (UK)300
Active, not recruiting
Not Applicable
Repeated application of bone marrow-derived stem cells to treat chronicpost-infarction heart failureChronic post-infarction heart failure due to an at least 3 months old myocardial infarction, treated with optimal medication according to the evidence-based guidelines, in NYHA stadium II-IIIand with open vessel / bypass sullpying the previously infarcted areaTherapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
EUCTR2011-000595-33-NLGoethe University Frankfurt676
Recruiting
Phase 3
Randomized controlled trial to compare the effects of single versus repeated intracoronary application of autologous bone marrow-derived mononuclear cells on total and SHFM-predicted mortality in patients with chronic post-infarction heart failure;REpetitive Progenitor cEll therapy in Advanced chronic hearT failure (REPEAT trial)Heart failure10019280
NL-OMON47617Goethe University Frankfurt20
Active, not recruiting
Phase 1
Repeated application of bone marrow-derived stem cells to treat chronic post-infarction heart failureChronic post-infarction heart failure due to an at least 3 months old myocardial infarction, treated with optimal medication according to the evidence-based guidelines, in NYHA stadium II-IIIand with open vessel / bypass sullpying the previously infarcted areaTherapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
EUCTR2011-000595-33-DEGoethe University Frankfurt676
Not yet recruiting
Not Applicable
A study of the effect of fentanyl boluses versus infusion on surgical plethysmographic index during surgery
CTRI/2020/11/029056Kasturba Medical College